Vanda Pharmaceuticals Inc (NAS:VNDA)
$ 5.04 -0.11 (-2.14%) Market Cap: 293.87 Mil Enterprise Value: -68.03 Mil PE Ratio: 0 PB Ratio: 0.54 GF Score: 81/100

Q3 2021 Vanda Pharmaceuticals Inc Earnings Call Transcript

Nov 03, 2021 / 08:30PM GMT
Release Date Price: $21.14 (+2.67%)
Operator

Good day, and thank you for standing by. Welcome to the Third Quarter 2021 Vanda Pharmaceuticals Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I'd now like to hand the conference over to your host today, Kevin Moran, Vanda's Chief Financial Officer. Please go ahead.

Kevin Patrick Moran
Vanda Pharmaceuticals Inc. - Senior VP, CFO & Treasurer

Thank you, Liz. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' third quarter 2021 performance. Our third quarter 2021 results were released this afternoon and are available on the SEC's EDGAR system and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.

Joining me on today's call is Dr. Mihales Polymeropoulos, our President, Chief Executive Officer and Chairman of the Board. Following my introductory remarks, Mihales will update you on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot